Drugs / Pfizer Bivalent vaccine
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT05911087 Comparator | Jun → Jul 2023 | — | Stemirna Therapeutics | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pfizer Bivalent vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05911087 ↗ |
| Modality | Messenger RNA (mRNA) | “Formulation mRNA” NCT05911087 ↗ |